Pfizer breast cancer drug succeeds in mid-stage trial

[riky]

Pfizer breast cancer drug succeeds in mid-stage trial

<p><a href="http://news.yahoo.com/pfizer-breast-cancer-drug-succeeds-mid-stage-trial-122720323--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/03NTowmqoPJ4jaXbOKA4Aw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-02-03T122720Z_1_CBREA120YLN00_RTROPTP_2_PFIZER.JPG" width="130" height="86" alt="The Pfizer logo is seen outside their world headquarters in New York" align="left" title="The Pfizer logo is seen outside their world headquarters in New York" border="0" /></a>Pfizer Inc's experimental breast cancer drug significantly delayed progression of symptoms in a mid-stage trial, meeting the study's primary goal and keeping Pfizer in the forefront of a race for a new standard of care for the disease. Pfizer shares were up nearly 4 percent on positive findings for the oral treatment, called palbociclib, one of the company's most important experimental drugs that some analysts believe could eventually claim annual sales of more than $5 billion, if approved. The trial tested the pill in post-menopausal patients with locally advanced or newly diagnosed breast cancer that had spread to other parts of the body. &quot;We are delighted with the final data,&quot; Pfizer said in a release, adding the company will discuss the successful data on progression-free survival with the U.S. Food and Drug Administration &quot;to determine next steps&quot; for palbociclib.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login